We use cookies on our website. Some are necessary for the operation of the website. You can also allow cookies for statistical purposes. You can adjust the data protection settings or agree to all cookies directly.
Data Protection Declaration
Imprint
Institute of Pharmacy
Institution
Section overview
Activities
- Research
Parent institution
Coordinated projects
Involved in research projects
- Berlin-Brandenburg Research Platform BB3R with Integrated Graduate Education 'Innovations in the 3R Research - Genetic Engineering, Tissue Engineering and Bioinformatics' - Subproject 4: 'Individualized pain suppression in mice' (Work program Dept. 9) and 'Development of a nanotoxicology test platform for testing the inhalation toxicity of nanoparticles in vitro' (work program Dept. 7)
- Biotechnological derived skin models for the cutaneous uptake of steroid hormone formulations
- Characterization of metabolizing enzymes and biotransformation of selected test substances in human in-vitro skin models to identify an optimal test system for dermato-toxicological and exposure-related studies
- Control of cellular adhesion and uptake of synthetic polymer nanoparticles by specific functionalization with biological target molecules - NanoScale
- Development of a biotransformation system for the metabolic activation of validated in vitro systems to study embryotoxicity
- Junior Research Group Toxicokinetic Modelling
- Refinement of the LCSA (loose-fit coculture-based sensitization assay)
Contact
Institute of Pharmacy
Königin-Luise-Straße 2 und 4
D-14195 Berlin
Berlin
Germany
Phone: 030 838-53270
Fax: 030 838-53854
Email: cwittig(@)zedat.fu-berlin.de
